U.S. Capital Markets Stock News

If you are wondering whether BioCryst Pharmaceuticals is attractively priced at its recent share price of US$7.58, you are not alone. This article will focus on what that number might really represent for long term investors. The stock has recently shown mixed momentum, with a 12.1% move over the past 7 days and 11.6% over 30 days, while the 1 year return sits at a decline of 8.6% and the 5 year return at a decline of 36.7%. These moves come against a backdrop of ongoing market attention on...

If you are wondering whether Costco Wholesale's near four-figure share price still offers value, you are not alone. This article is designed to help you frame that question clearly. The stock last closed at US$986.02, with returns of a 3.2% decline over the past 7 days, 0.3% over 30 days, 15.4% year to date, a 4.3% decline over 1 year, 110.9% over 3 years and 213.9% over 5 years. Recent coverage has focused on Costco's consistent membership model, its large-scale warehouse footprint and its...

American Tower (NYSE:AMT) recently completed a $365 million share buyback program. The company's CFO executed significant insider selling around the same period, drawing extra attention to management's actions. American Tower appointed a new chief accounting officer, marking a meaningful change in its finance leadership team. American Tower, trading at $190.05 at last close, is in the spotlight as investors weigh these moves together rather than in isolation. The stock is up 6.3% over the...

Albemarle (ALB) is back in focus after management moved to idle its Kemerton lithium hydroxide plant in Western Australia, while guiding to flat 2026 volumes and aiming for higher profitability as lithium prices recover. See our latest analysis for Albemarle. The Kemerton announcement and 2026 guidance landed after a period of sharp share price moves, with Albemarle up 5.40% on a 1 day share price return and 41.72% over 90 days. The 1 year total shareholder return of 123.63% contrasts with a...

HCA Healthcare recently featured at the ViVE 2026 conference in Los Angeles while expanding its footprint with new facilities in Florida, Texas, and Utah and holding weekly “Talent Thursdays” hiring events ahead of the HCA Florida Gainesville Hospital opening in May 2026. Together with broadened analyst optimism around artificial intelligence and potential Medicaid supplemental payment updates, these moves highlight how HCA is leaning into technology and physical capacity expansion to...

Delek US Holdings (DK) has been drawing attention after reporting annual revenue of US$10.67b alongside a net loss of US$541.2m. This combination is putting both its refining operations and valuation under closer investor scrutiny. See our latest analysis for Delek US Holdings. The latest results land as Delek US Holdings’ share price sits at US$33.25, with a 17.82% 1 month share price return but a 13.05% 3 month share price decline. The 1 year total shareholder return of 113.50% points to...

What recent returns say about QMMM Holdings (QMMM) QMMM Holdings (QMMM) has attracted attention after a 19.4% one day move, a return of 19.4% over the past 3 months, and a year to date gain of 87.44%. See our latest analysis for QMMM Holdings. That surge in the 1 day share price return and the latest share price of $119.4 comes on top of a 90 day share price return of 19.4% and a very large year to date share price gain. The 1 year total shareholder return is also very large, suggesting...

Merck (NYSE:MRK) is restructuring its Human Health division into two units: Oncology and Specialty, Pharma & Infectious Diseases. The company has announced new executive appointments to lead each unit as part of this reorganization. The move is intended to sharpen focus on cancer care and the broader portfolio ahead of Keytruda patent expiration. With a current share price of $123.82, Merck comes into this reorganization after a strong run, with the stock up 14.5% over the past 30 days and...

Edwards Lifesciences, ticker NYSE:EW, plans to launch new left atrial appendage closure products in 2026. The products will build on the company’s existing surgical franchise to enter a growing treatment segment for atrial fibrillation patients. The move broadens Edwards Lifesciences’ portfolio beyond its core offerings in structural heart therapies. Edwards Lifesciences, trading at $82.44, is preparing to extend its reach with new left atrial appendage closure devices that sit alongside...

In recent weeks, TTM Technologies reported an exceptionally strong fourth quarter with 19% year‑over‑year sales growth, raised its outlook, and gained relief from the U.S. Supreme Court’s decision to strike down global tariffs that had pressured its costs. At the same time, TTM has been highlighted as a key supplier for AI‑driven data center buildouts and defense programs, attracting fresh institutional interest from Metavasi Capital and reinforcing its role at the center of high‑reliability...

If you are wondering whether Helmerich & Payne at around US$35.13 is offering good value today, you are not alone. This article will walk through what the current market price might be implying. The stock has seen returns of 5.8% over the past week, 8.8% over the last 30 days, 17.3% year to date and 32.8% over the past year, while the 3 year return is a 4.0% decline and the 5 year return is 43.5%. Recent price moves sit against a backdrop of ongoing interest in energy and drilling companies,...

In February 2026, the Florida Department of Management Services selected ICF International as an awardee on its expanded three-year comprehensive management services contract, making the firm eligible to support statewide programs across all service categories, including disaster recovery, grants and program management, environmental and infrastructure support, workforce development, and technology modernization. A distinctive aspect of this award is Florida’s ability to tap both ICF’s...

In February 2026, Cloudflare announced it had completed what it calls the world’s first full Secure Access Service Edge platform with post-quantum encryption across Cloudflare One, while also reporting 2025 results showing US$614.51 million in fourth-quarter revenue and US$2.17 billion in full-year revenue alongside a continued net loss. By extending post-quantum protection to wide-area networking and partnering with Mastercard on attack-surface monitoring, Cloudflare is tying its growth...

CVB Financial (CVBF) has drawn investor attention after recent share price pressure, with the stock showing negative returns over the past week, month, and past 3 months despite a modest gain year to date. See our latest analysis for CVB Financial. The recent 1 day share price return of 4.79% and 7 day share price return of 5.11% add to a softer 90 day share price return of 3.56%. At the same time, the year to date share price return of 4.45% alongside a 1 year total shareholder return of...

Recent performance snapshot Tencent Music Entertainment Group (TME) has been drawing attention after recent share price moves, with the stock closing at $14.71 and showing mixed returns over the past year and multi year periods. Short term performance has been weak, with a 1 day return of a 3.2% decline, about a 7.2% decline over the past week, and a 1 month return of a 12.4% decline. Over the past 3 months, the stock is down 20.1%, while year to date it is down 17.6%. Over longer horizons,...

Lowe's Companies (NYSE:LOW) is cutting about 600 corporate and support roles as it reallocates resources toward store operations and customer facing activities. The company says the reductions are aimed at refocusing spending and talent on its retail footprint and in store execution. Separately, Lowe's drew attention after a customer was asked to sign a confidentiality agreement to receive a product refund. The confidentiality incident has raised questions about how the retailer handles...

Why Gossamer Bio’s PROSERA readout matters now Gossamer Bio (GOSS) has drawn fresh attention after releasing topline Phase 3 PROSERA data for seralutinib in pulmonary arterial hypertension and scheduling a special call to review the results and potential next steps with regulators. See our latest analysis for Gossamer Bio. The unveiling of the PROSERA Phase 3 topline data and the planned FDA discussions come after a sharp reset in sentiment, with a 30 day share price return of 84.32% decline...

Sociedad Química y Minera de Chile (SQM) has been drawing attention after a mixed recent run, with the stock up over the past 3 months but showing a decline over the past month. See our latest analysis for Sociedad Química y Minera de Chile. At a share price of $73.07, Sociedad Química y Minera de Chile has a 7 day share price return of 3.05% and a 30 day share price return showing a 14.47% decline. The 1 year total shareholder return of 83.92% contrasts with a 3 year total shareholder return...

Ocular Therapeutix recently reported topline results from its SOL-1 Phase 3 superiority trial of AXPAXLI for wet age-related macular degeneration, a disclosure that has triggered investor scrutiny and a law firm’s review of potential securities law compliance. The company is now preparing detailed SOL-1 data presentations and multiple investor events, signaling that how it communicates and contextualizes these results could materially influence perceptions of AXPAXLI’s clinical profile and...

Why Benchmark Electronics (BHE) Is Back on Investors’ Radar Benchmark Electronics (BHE) just reported a strong quarter, highlighting tighter operating margins and ongoing cash returns to shareholders as it tilts its business mix toward higher margin defense, medical, and semiconductor equipment programs. See our latest analysis for Benchmark Electronics. The share price has cooled slightly in the last week after a strong run, with a 30 day share price return of 17.38% and year to date gain of...

Figure Technology Solutions (FIGR) is back in focus after completing a US$150 million follow on equity offering at US$32 per Class A share, together with preliminary guidance for its fourth quarter and full year 2025 results. See our latest analysis for Figure Technology Solutions. The follow on offering and fresh guidance come after a volatile spell for Figure Technology Solutions. A 1 day share price return of 3.76% took the stock to US$30.215, while a 30 day share price return of 51.89%...

Coca-Cola FEMSA, S.A.B. de C.V. reported past fourth-quarter 2025 sales of MX$77,493 million and net income of MX$7,501 million, with full-year 2025 sales of MX$291,147 million and net income of MX$23,845 million, all modestly higher than the prior year. This steady earnings and revenue expansion, alongside existing analyst interest and dividend income, underscores a picture of operational consistency that may matter for long-term investors assessing Coca-Cola FEMSA’s role in Latin American...

RenaissanceRe Holdings’ board previously approved a quarterly dividend increase to US$0.41 per share from US$0.40, payable on March 31, 2026 to shareholders of record on March 13, 2026, and reported completing share repurchases totaling 3,065,414 shares across two programs for a combined US$780.48 million. The company’s three-decade pattern of annual dividend increases, paired with recently completed buybacks that retired nearly one-twentieth of its share base, highlights a sustained...

SouthState Bank (SSB) is back on investor radars after recent share moves, with the stock closing at $100.58 and showing mixed returns over the past week, month, and past three months. See our latest analysis for SouthState Bank. The recent 1 day share price return of a 4.61% decline contrasts with SouthState Bank’s 11.84% 3 month share price return and 33.78% 3 year total shareholder return, which may indicate that longer term momentum remains stronger than the latest pullback suggests. If...